See more : Apontis Pharma AG (APPH.DE) Income Statement Analysis – Financial Results
Complete financial analysis of Trupanion, Inc. (TRUP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Trupanion, Inc., a leading company in the Insurance – Specialty industry within the Financial Services sector.
You may be interested
- Ascend Wellness Holdings, Inc. (AAWH) Income Statement Analysis – Financial Results
- ShinHsiung Natural Gas Inc. (8908.TWO) Income Statement Analysis – Financial Results
- CF Energy Corp. (CGFEF) Income Statement Analysis – Financial Results
- Inventus Mining Corp. (IVS.V) Income Statement Analysis – Financial Results
- Hindcon Chemicals Limited (HINDCON.NS) Income Statement Analysis – Financial Results
Trupanion, Inc. (TRUP)
About Trupanion, Inc.
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. The company was founded in 2000 and is headquartered in Seattle, Washington.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.11B | 905.18M | 698.99M | 502.03M | 383.94M | 303.96M | 242.67M | 188.23M | 146.96M | 115.91M | 83.83M | 55.53M | 37.05M |
| Cost of Revenue | 977.59M | 782.99M | 594.65M | 420.13M | 319.01M | 252.59M | 199.62M | 154.94M | 121.73M | 96.04M | 68.19M | 44.32M | 29.00M |
| Gross Profit | 131.02M | 122.19M | 104.35M | 81.90M | 64.92M | 51.37M | 43.05M | 33.29M | 25.23M | 19.87M | 15.64M | 11.21M | 8.04M |
| Gross Profit Ratio | 11.82% | 13.50% | 14.93% | 16.31% | 16.91% | 16.90% | 17.74% | 17.68% | 17.17% | 17.15% | 18.66% | 20.19% | 21.71% |
| Research & Development | 21.40M | 25.13M | 16.87M | 9.95M | 10.07M | 9.25M | 9.77M | 9.53M | 11.22M | 9.90M | 4.89M | 3.41M | 1.50M |
| General & Administrative | 60.21M | 39.38M | 31.89M | 21.85M | 20.97M | 18.16M | 16.82M | 15.21M | 15.56M | 14.31M | 8.65M | 6.20M | 4.29M |
| Selling & Marketing | 0.00 | 89.50M | 78.65M | 47.84M | 35.45M | 25.00M | 19.10M | 15.25M | 15.23M | 11.61M | 9.09M | 7.15M | 5.21M |
| SG&A | 60.21M | 128.88M | 110.54M | 69.68M | 56.42M | 43.16M | 35.92M | 30.45M | 30.79M | 25.92M | 17.74M | 13.34M | 9.50M |
| Other Expenses | 90.07M | 10.92M | 11.97M | 7.07M | 1.63M | 1.31M | 1.24M | -37.00K | 9.00K | 1.49M | -42.00K | -98.00K | -1.00K |
| Operating Expenses | 171.68M | 164.93M | 139.37M | 86.70M | 66.49M | 52.41M | 45.69M | 39.99M | 42.00M | 35.82M | 22.63M | 16.75M | 10.99M |
| Cost & Expenses | 1.15B | 947.93M | 734.02M | 506.83M | 385.50M | 305.00M | 245.31M | 194.93M | 163.74M | 131.86M | 90.82M | 61.07M | 40.00M |
| Interest Income | 0.00 | 3.00M | 10.00K | 1.38M | 1.35M | 0.00 | 0.00 | 119.00K | 75.00K | 73.00K | 86.00K | 75.00K | 69.00K |
| Interest Expense | 12.08M | 4.27M | 10.00K | 1.38M | 1.35M | 1.20M | 533.00K | 218.00K | 325.00K | 6.73M | 609.00K | 535.00K | 690.00K |
| Depreciation & Amortization | 12.47M | 10.92M | 11.97M | 7.07M | 5.63M | 4.51M | 4.23M | 3.85M | 2.54M | 1.67M | 892.00K | 349.00K | 199.00K |
| EBITDA | -20.48M | -29.01M | -23.25M | 2.73M | 5.34M | 4.78M | 2.83M | -2.79M | -14.22M | -12.78M | -6.77M | -5.44M | -2.94M |
| EBITDA Ratio | -1.85% | -3.20% | -3.33% | 0.54% | 1.39% | 1.57% | 1.17% | -1.47% | -9.68% | -11.03% | -7.28% | -9.39% | -7.25% |
| Operating Income | -40.66M | -42.75M | -35.03M | -4.35M | -291.00K | -1.05M | -2.64M | -6.70M | -16.78M | -15.95M | -6.99M | -5.54M | -2.95M |
| Operating Income Ratio | -3.67% | -4.72% | -5.01% | -0.87% | -0.08% | -0.34% | -1.09% | -3.56% | -11.41% | -13.76% | -8.33% | -9.97% | -7.97% |
| Total Other Income/Expenses | -4.38M | -1.20M | -24.00K | -800.00K | 280.00K | 111.00K | 711.00K | -160.00K | -316.00K | -5.24M | -1.28M | -787.00K | -876.00K |
| Income Before Tax | -45.04M | -44.20M | -35.22M | -5.73M | -1.64M | -934.00K | -1.93M | -6.86M | -17.09M | -21.18M | -8.27M | -6.33M | -3.83M |
| Income Before Tax Ratio | -4.06% | -4.88% | -5.04% | -1.14% | -0.43% | -0.31% | -0.80% | -3.64% | -11.63% | -18.28% | -9.86% | -11.39% | -10.33% |
| Income Tax Expense | -342.00K | 476.00K | 310.00K | 113.00K | 169.00K | -7.00K | -428.00K | 38.00K | 114.00K | -7.00K | -92.00K | 84.00K | 92.00K |
| Net Income | -44.69M | -44.67M | -35.53M | -5.84M | -1.81M | -927.00K | -1.50M | -6.90M | -17.21M | -21.18M | -8.18M | -6.41M | -3.92M |
| Net Income Ratio | -4.03% | -4.94% | -5.08% | -1.16% | -0.47% | -0.30% | -0.62% | -3.66% | -11.71% | -18.27% | -9.75% | -11.54% | -10.58% |
| EPS | -1.08 | -1.10 | -0.89 | -0.16 | -0.05 | -0.03 | -0.05 | -0.24 | -0.62 | -0.76 | -6.23 | -4.18 | -0.21 |
| EPS Diluted | -1.08 | -1.10 | -0.89 | -0.16 | -0.05 | -0.03 | -0.05 | -0.24 | -0.62 | -0.76 | -6.23 | -4.18 | -0.21 |
| Weighted Avg Shares Out | 41.44M | 40.77M | 40.14M | 35.86M | 34.65M | 31.96M | 29.59M | 28.53M | 27.64M | 27.83M | 1.31M | 1.53M | 18.37M |
| Weighted Avg Shares Out (Dil) | 41.44M | 40.77M | 40.14M | 35.86M | 34.65M | 31.96M | 29.59M | 28.53M | 27.64M | 27.83M | 1.31M | 1.53M | 18.37M |
Trupanion, leading pet medical insurance provider, shares respiratory health data amid rising Canine Respiratory Illness concerns
SEATTLE, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, today hosted an audience of thousands during a live online event, sharing proprietary data and insights in partnership with...
Speculator's Watch List: 7 Stocks Ripe for a Short-Squeeze Windfall
Easily one of the most powerful catalysts in the capital markets, short-squeeze stocks deserve to be on your radar because of their ability to foster panic. Subsequently, this panic forces bearish traders to cover their short positions, in turn making...
Global Veterinary Authorities Delve into Trupanion Data, Gaining Insight into Current Canine Respiratory Illness Concerns
Trupanion to convene canine respiratory illness Q&A with expert veterinarian panelists live on November 30 Trupanion to convene canine respiratory illness Q&A with expert veterinarian panelists live on November 30
7 Short-Squeeze Stocks That Could Serve Up Serious Rewards
Few other phenomena scare bearish traders than an unexpected momentum shift that forces an awful decision, thereby imbuing the concept of short-squeeze stocks with unignorable leverage. After all, when bulls get things wrong, they generally risk their principal.
Supporting Your Pet's Behavioral Health During the Back-to-Office Transition: Join Trupanion's YouTube Premiere for Expert Guidance
- Expert panelists to share insights into understanding and managing behavioral health issues in pets - Premiere comes at a time of rising veterinary visits related to behavioral concerns in pets SEATTLE, Nov. 20, 2023 (GLOBE NEWSWIRE) -- As pet...
Trupanion's Holiday Safety Guide: Protecting Your Pets During Festive Seasons
SEATTLE, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The holiday season, a period synonymous with joy, merriment, and family gatherings, also presents unique challenges for our beloved pets. As we immerse ourselves in festive activities, Trupanion, the leading provider of pet...
Trupanion: Watch New CFO And Profitability Improvement Timeline
Trupanion has appointed a new Chief Financial Officer, after its former CFO left his position in June this year. Trupanion expects its Subscription Business' operating margin to expand to 15% in Q4 2024, as there is a time lag for...
Does Trupanion (TRUP) Have the Potential to Rally 38.83% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 38.8% in Trupanion (TRUP). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an...
Why Trupanion Stock Soared Today
Trupanion easily exceeded estimates with its third-quarter report, including 22% quarterly revenue growth and a significantly narrowed net loss. Total enrolled pets grew 19%, while subscription revenue climbed 20%.
Trupanion, Inc. (TRUP) Q3 2023 Earnings Call Transcript
Trupanion, Inc. (TRUP) Q3 2023 Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports